CHEBI:50427 - platelet aggregation inhibitor

Main

ChEBI Ontology

Automatic Xrefs

Reactions

Pathways

Models

ChEBI Name platelet aggregation inhibitor ChEBI ID CHEBI:50427 Definition A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Stars This entity has been manually annotated by the ChEBI Team. ChEBI Ontology Outgoing platelet aggregation inhibitor (CHEBI:50427) is a hematologic agent (CHEBI:50248) Incoming β-benzoyloxypaeoniflorin (CHEBI:132791) has role platelet aggregation inhibitor (CHEBI:50427) δ-guaiene (CHEBI:63447) has role platelet aggregation inhibitor (CHEBI:50427) (E)-2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside (CHEBI:140850) has role platelet aggregation inhibitor (CHEBI:50427) (E)-3-tosylacrylonitrile (CHEBI:85928) has role platelet aggregation inhibitor (CHEBI:50427) (S)-glaucine (CHEBI:5373) has role platelet aggregation inhibitor (CHEBI:50427) 12-HPEPE (CHEBI:78909) has role platelet aggregation inhibitor (CHEBI:50427) 12-HPEPE(1−) (CHEBI:78078) has role platelet aggregation inhibitor (CHEBI:50427) 2-acetamidophenol (CHEBI:143107) has role platelet aggregation inhibitor (CHEBI:50427) 4,4'-dihydroxybenzyl sulfone (CHEBI:65786) has role platelet aggregation inhibitor (CHEBI:50427) 4-phenyl-3-furoxancarbonitrile (CHEBI:180495) has role platelet aggregation inhibitor (CHEBI:50427) 6-oxoprostaglandin E1 (CHEBI:28269) has role platelet aggregation inhibitor (CHEBI:50427) cis-ferulic acid (CHEBI:76117) has role platelet aggregation inhibitor (CHEBI:50427) N-tert-butyl(3,5,6-trimethylpyrazin-2-yl)methanimine N-oxide (CHEBI:133247) has role platelet aggregation inhibitor (CHEBI:50427) N-trans-cinnamoyltyramine (CHEBI:177872) has role platelet aggregation inhibitor (CHEBI:50427) S-nitroso-L-cysteine (CHEBI:138935) has role platelet aggregation inhibitor (CHEBI:50427) S-nitrosoglutathione (CHEBI:50091) has role platelet aggregation inhibitor (CHEBI:50427) acadesine (CHEBI:28498) has role platelet aggregation inhibitor (CHEBI:50427) acetylsalicylic acid (CHEBI:15365) has role platelet aggregation inhibitor (CHEBI:50427) ACT-333679 (CHEBI:90848) has role platelet aggregation inhibitor (CHEBI:50427) actinodaphnine (CHEBI:2444) has role platelet aggregation inhibitor (CHEBI:50427) aglafolin (CHEBI:65374) has role platelet aggregation inhibitor (CHEBI:50427) anagrelide (CHEBI:142290) has role platelet aggregation inhibitor (CHEBI:50427) anagrelide hydrochloride (CHEBI:55345) has role platelet aggregation inhibitor (CHEBI:50427) angelitriol (CHEBI:132402) has role platelet aggregation inhibitor (CHEBI:50427) angelol-J (CHEBI:132768) has role platelet aggregation inhibitor (CHEBI:50427) asperenone (CHEBI:133813) has role platelet aggregation inhibitor (CHEBI:50427) azelastine (CHEBI:2950) has role platelet aggregation inhibitor (CHEBI:50427) azelastine hydrochloride (CHEBI:2951) has role platelet aggregation inhibitor (CHEBI:50427) bassiatin (CHEBI:65465) has role platelet aggregation inhibitor (CHEBI:50427) BAY 41-2272 (CHEBI:142435) has role platelet aggregation inhibitor (CHEBI:50427) benzo[d]isothiazol-3-one (CHEBI:167099) has role platelet aggregation inhibitor (CHEBI:50427) beraprost (CHEBI:135633) has role platelet aggregation inhibitor (CHEBI:50427) beraprost sodium (CHEBI:31270) has role platelet aggregation inhibitor (CHEBI:50427) bianfugenine (CHEBI:132719) has role platelet aggregation inhibitor (CHEBI:50427) bis-(4-hydroxybenzyl)ether (CHEBI:65501) has role platelet aggregation inhibitor (CHEBI:50427) cangrelor (CHEBI:90841) has role platelet aggregation inhibitor (CHEBI:50427) cangrelor tetrasodium (CHEBI:90836) has role platelet aggregation inhibitor (CHEBI:50427) carmoxirole (CHEBI:64200) has role platelet aggregation inhibitor (CHEBI:50427) carmoxirole hydrochloride (CHEBI:64199) has role platelet aggregation inhibitor (CHEBI:50427) cilostazol (CHEBI:31401) has role platelet aggregation inhibitor (CHEBI:50427) clonixin (CHEBI:76200) has role platelet aggregation inhibitor (CHEBI:50427) clonixin lysine salt (CHEBI:76201) has role platelet aggregation inhibitor (CHEBI:50427) clopidogrel (CHEBI:37941) has role platelet aggregation inhibitor (CHEBI:50427) clopidogrel sulfate (CHEBI:3759) has role platelet aggregation inhibitor (CHEBI:50427) cyclomorusin A (CHEBI:132868) has role platelet aggregation inhibitor (CHEBI:50427) cytochalasin B (CHEBI:23527) has role platelet aggregation inhibitor (CHEBI:50427) diallyl trisulfide (CHEBI:78492) has role platelet aggregation inhibitor (CHEBI:50427) dilazep (CHEBI:92842) has role platelet aggregation inhibitor (CHEBI:50427) dilazep dihydrochloride (CHEBI:31493) has role platelet aggregation inhibitor (CHEBI:50427) dipyridamole (CHEBI:4653) has role platelet aggregation inhibitor (CHEBI:50427) dithiadene (CHEBI:167625) has role platelet aggregation inhibitor (CHEBI:50427) droxicam (CHEBI:76133) has role platelet aggregation inhibitor (CHEBI:50427) edoxaban (CHEBI:85973) has role platelet aggregation inhibitor (CHEBI:50427) edoxaban tosylate (CHEBI:85975) has role platelet aggregation inhibitor (CHEBI:50427) edoxaban tosylate hydrate (CHEBI:85974) has role platelet aggregation inhibitor (CHEBI:50427) EET (CHEBI:64007) has role platelet aggregation inhibitor (CHEBI:50427) eptifibatide (CHEBI:291902) has role platelet aggregation inhibitor (CHEBI:50427) forskolin (CHEBI:42471) has role platelet aggregation inhibitor (CHEBI:50427) galgravin (CHEBI:132648) has role platelet aggregation inhibitor (CHEBI:50427) herquline A (CHEBI:229724) has role platelet aggregation inhibitor (CHEBI:50427) herquline B (CHEBI:66012) has role platelet aggregation inhibitor (CHEBI:50427) hydroxysafflor yellow A (CHEBI:139030) has role platelet aggregation inhibitor (CHEBI:50427) iloprost (CHEBI:63916) has role platelet aggregation inhibitor (CHEBI:50427) isobavachalcone (CHEBI:28106) has role platelet aggregation inhibitor (CHEBI:50427) isotanshinone IIB (CHEBI:66098) has role platelet aggregation inhibitor (CHEBI:50427) LFM-A13 (CHEBI:183517) has role platelet aggregation inhibitor (CHEBI:50427) lificiguat (CHEBI:142430) has role platelet aggregation inhibitor (CHEBI:50427) methyl brevifolincarboxylate (CHEBI:66711) has role platelet aggregation inhibitor (CHEBI:50427) milrinone (CHEBI:50693) has role platelet aggregation inhibitor (CHEBI:50427) miroprofen (CHEBI:76249) has role platelet aggregation inhibitor (CHEBI:50427) ML355 (CHEBI:195557) has role platelet aggregation inhibitor (CHEBI:50427) neobavaisoflavone (CHEBI:66614) has role platelet aggregation inhibitor (CHEBI:50427) nisoldipine (CHEBI:7577) has role platelet aggregation inhibitor (CHEBI:50427) oleoyl danshenxinkun A (CHEBI:66819) has role platelet aggregation inhibitor (CHEBI:50427) oleoyl neocryptotanshinone (CHEBI:66820) has role platelet aggregation inhibitor (CHEBI:50427) procainamide (CHEBI:8428) has role platelet aggregation inhibitor (CHEBI:50427) prostaglandin E1 (CHEBI:15544) has role platelet aggregation inhibitor (CHEBI:50427) resolvin D5 (CHEBI:138645) has role platelet aggregation inhibitor (CHEBI:50427) sapinmusaponin Q (CHEBI:66169) has role platelet aggregation inhibitor (CHEBI:50427) sapinmusaponin R (CHEBI:66170) has role platelet aggregation inhibitor (CHEBI:50427) sciadopitysin (CHEBI:9050) has role platelet aggregation inhibitor (CHEBI:50427) selexipag (CHEBI:90844) has role platelet aggregation inhibitor (CHEBI:50427) sevoflurane (CHEBI:9130) has role platelet aggregation inhibitor (CHEBI:50427) SKF-96365 hydrochloride (CHEBI:145121) has role platelet aggregation inhibitor (CHEBI:50427) sophoraflavanone B (CHEBI:50207) has role platelet aggregation inhibitor (CHEBI:50427) splitomicin (CHEBI:75272) has role platelet aggregation inhibitor (CHEBI:50427) surfactin (CHEBI:29681) has role platelet aggregation inhibitor (CHEBI:50427) surfactin C (CHEBI:71978) has role platelet aggregation inhibitor (CHEBI:50427) syringetin (CHEBI:18215) has role platelet aggregation inhibitor (CHEBI:50427) taiwanin C (CHEBI:191411) has role platelet aggregation inhibitor (CHEBI:50427) tetramethylpyrazine (CHEBI:133246) has role platelet aggregation inhibitor (CHEBI:50427) ticagrelor (CHEBI:68558) has role platelet aggregation inhibitor (CHEBI:50427) ticlopidine (CHEBI:9588) has role platelet aggregation inhibitor (CHEBI:50427) treprostinil (CHEBI:50861) has role platelet aggregation inhibitor (CHEBI:50427) troglitazone (CHEBI:9753) has role platelet aggregation inhibitor (CHEBI:50427) vitexin (CHEBI:16954) has role platelet aggregation inhibitor (CHEBI:50427) vorapaxar (CHEBI:82702) has role platelet aggregation inhibitor (CHEBI:50427) vorapaxar sulfate (CHEBI:83314) has role platelet aggregation inhibitor (CHEBI:50427) xenocyloin (CHEBI:156365) has role platelet aggregation inhibitor (CHEBI:50427) yinyanghuo A (CHEBI:66492) has role platelet aggregation inhibitor (CHEBI:50427) yinyanghuo B (CHEBI:66493) has role platelet aggregation inhibitor (CHEBI:50427) partial prostacyclin agonist (CHEBI:51577) is a platelet aggregation inhibitor (CHEBI:50427) platelet glycoprotein-IIb/IIIa receptor antagonist (CHEBI:50433) is a platelet aggregation inhibitor (CHEBI:50427) Synonym Source platelet aggregation inhibitors ChEBI Last Modified 07 March 2024